Agence de la biomédecine
Agence de la biomédecine is the French national public health agency coordinating organ and tissue donation, bone marrow and cord blood registries, medically assisted reproduction, gamete donation, genetics, and biovigilance under the Ministry of Health. It serves French transplant patients, donors, and reproductive medicine users as a state-funded monopoly authority.
- Company typePrivate
- Founded2004
- HeadquartersLa Plaine-saint-denis, France
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Agence de la biomédecine does
Agence de la biomédecine is a French public administrative establishment (établissement public administratif) founded in 2004 and operating under the French Ministry of Health. It serves as the sole national competent authority for biomedicine in France, with statutory responsibility for coordinating organ and tissue donation and transplantation, managing the national bone marrow donor registry, overseeing cord blood banking, authorizing medically assisted reproduction centers, regulating embryo research, and operating biovigilance systems across organs, tissues, cells, gametes, and breast milk. Its mandate also extends to medical genetics, prenatal and preimplantation diagnosis, and a Neuroscience Watch function that informs Parliament and Government on emerging bioethical issues.
The agency serves French patients requiring organ or stem cell transplants, individuals seeking medically assisted reproduction, donors and recipients of gametes and breast milk, and hereditary disease patients needing genetic counseling. It maintains dedicated public-facing portals (dondorganes.fr, dondemoelleosseuse.fr, dondovocytes.fr, dondespermatozoides.fr, procreation-medicale.fr, genetique-medicale.fr) and an active social media presence to drive donor registration and public awareness. Internally it operates registries, observatories (including the Chronic Kidney Disease Observatory), and vigilance systems that produce annual reports on biovigilance and medically assisted reproduction outcomes.
The business model is non-commercial: the agency is funded through the French state budget and the Sécurité Sociale national health insurance system, with services delivered through the public hospital network, transplant centers, tissue banks, and authorized reproductive medicine establishments. It employs 251–500 staff headquartered in La Plaine-Saint-Denis, France, and publishes annual reports covering biovigilance and assisted reproduction vigilance rather than financial disclosures. No revenue, pricing, or ownership changes are publicly available because the entity has no commercial shareholders and operates purely as a public-sector instrument.
Agence de la biomédecine firmographics
Firmographics- Name
- Agence de la biomédecine
- Legal name
- Agence de la biomédecine
- Website
- https://agence-biomedecine.fr
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Agence de la biomédecine is the French national public health agency coordinating organ and tissue donation, bone marrow and cord blood registries, medically assisted reproduction, gamete donation, genetics, and biovigilance under the Ministry of Health. It serves French transplant patients, donors, and reproductive medicine users as a state-funded monopoly authority.
- Ownership category
- akta.pro rank
Agence de la biomédecine industry classification
Industry- Product category
- Public Health Biomedicine Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
- akta.pro secondary industries
- Biologics & Vaccine Regulators (HLAJADAB), Maternal, Child & Family Health Departments (HLAJAAAK)
Keywords
Where Agence de la biomédecine is headquartered
LocationHeadquarters
- HQ city
- La Plaine-saint-denis
- HQ country
- France
- HQ region
- Europe
Markets served
Agence de la biomédecine business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Distribution channels1 record
Marketing channels3 records
Agence de la biomédecine product offering
Product offeringCore offering
Agence de la biomédecine is the French national public health agency that coordinates, regulates, and oversees activities related to organ and tissue donation and transplantation, bone marrow and cord blood registries, medically assisted reproduction, gamete donation, medical genetics, prenatal and preimplantation diagnosis, embryo research oversight, neuroscience policy monitoring, and breast milk donation. It manages national donor registries, allocates organs to patients on transplant waiting lists, authorizes assisted reproduction centers, and publishes annual biovigilance and AMP vigilance reports.
Product overview
Agence de la biomédecine is a French government agency that operates as a unified national platform managing multiple biomedicine-related public health services. The portfolio includes organ and tissue donation transplantation coordination, bone marrow donor registry management, cord blood banking, assisted reproduction, gamete donation, medical genetics, prenatal and preimplantation diagnosis, embryo research oversight, neuroscience monitoring, and breast milk banking. The agency maintains specialized informational portals including dondemoelleosseuse.fr, dondorganes.fr, dondovocytes.fr, dondespermatozoides.fr, dondeprocreationmedicale.fr, and genetique-medicale.fr to serve specific donor and patient audiences. Annual reports covering biovigilance and medically assisted reproduction vigilance are published annually.
Differentiator
Problem solved
Functional benefit
Brands
- dondemoelleosseuse.fr: Dedicated website for bone marrow donation awareness and information
- dondorganes.fr
- dondovocytes.fr
- dondespermatozoides.fr
- dondeprocreationmedicale.fr
- genetique-medicale.fr
Products and services
- Organ and tissue donation and transplantation coordination Coordinates organ and tissue donation and transplantation activities across France, manages the national transplant waiting list, and ensures equitable access to transplants for patients with end-stage organ failure.
- Chronic kidney disease observatory Monitors chronic kidney disease prevalence, treatment patterns, and patient outcomes across France to inform public health policy and transplantation planning.
- Bone marrow donation and transplantation coordination Manages the national bone marrow donor registry and coordinates stem cell transplants for patients with serious blood diseases such as leukemia.
- Cord blood donation and transplantation coordination Oversees the collection and banking of umbilical cord blood containing hematopoietic stem cells for therapeutic use in patients with serious blood diseases.
- Medically assisted reproduction (AMP) oversight Authorizes and oversees medically assisted reproduction centers across France, enabling access to IVF and related procedures for individuals and couples who are infertile or unable to conceive naturally.
- Gamete donation program Manages sperm and oocyte donation programs, enabling women and couples to access medically assisted procreation with donated gametes.
- Medical genetics services Provides oversight and coordination of genetic testing and counseling services to detect hereditary diseases and inform treatment decisions.
- Prenatal diagnosis Coordinates prenatal testing to detect serious and incurable diseases, malformations, or genetic disorders during pregnancy.
- Preimplantation diagnosis Offers preimplantation genetic diagnosis for couples at risk of passing serious genetic diseases to their children.
- Embryo research oversight Regulates and oversees research on human embryos and human embryonic stem cells in compliance with French bioethics law.
- Neuroscience policy watch Monitors scientific developments in neuroscience to inform Parliament, Government, and stakeholders about research advances and their ethical and regulatory implications.
- Breast milk donation coordination Coordinates breast milk donation through lactariums for therapeutic use by vulnerable newborns, especially premature babies.
Companies that use Agence de la biomédecine
Customer profileSegments1 record
Ideal customer profiles4 records
Agence de la biomédecine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Agence de la biomédecine partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Agence de la biomédecine competitors and assessment
Company assessmentOthers
- European Society for Blood and Marrow Transplantation (EBMT): European scientific society for blood and marrow transplantation that collaborates with national registries including Agence de la biomédecine on cross-border donor matching and transplantation standards — adjacent ecosystem participant rather than direct operator.
Direct peers
- Deutsche Stiftung Organtransplantation (DSO): Germany's national organ procurement foundation coordinating post-mortem organ donation across the country, comparable to Agence de la biomédecine's core organ donation coordination function.
- Canadian Blood Services: Canada's national blood operator with an expanded mandate into organ and stem cell registries and transplantation, directly comparable to Agence de la biomédecine's national coordination role across multiple biological product categories.
- Organización Nacional de Trasplantes (ONT): Spain's national transplant organization coordinating organ procurement, allocation, and transplantation nationwide — a direct functional counterpart to Agence de la biomédecine's organ donation and transplantation mandate.
- National Marrow Donor Program / Be The Match: US-based bone marrow and stem cell donor registry that operates the world's largest hematopoietic stem cell donor file — directly comparable to Agence de la biomédecine's bone marrow donor registry and stem cell transplant coordination.
- Centro Nazionale Trapianti (CNT): Italy's national transplant center under the Ministry of Health, coordinating organ, tissue, and cell donation and transplantation — structurally analogous to Agence de la biomédecine as a ministerial national authority.
- NHS Blood and Transplant: UK national authority for blood, organ, and stem cell donation and transplantation, performing the same organ allocation, donor registry management, and biovigilance functions as Agence de la biomédecine within the UK public health system.
Regional players
- Australian Organ and Tissue Authority: Australian government agency responsible for national organ and tissue donation reform, performing a comparable national coordination role to Agence de la biomédecine but operating in a different geography.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Agence de la biomédecine social profiles
Digital presenceAgence de la biomédecine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Agence de la biomédecine leadership team
Management profileNumber of profiles
Agence de la biomédecine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Agence de la biomédecine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Agence de la biomédecine
What does Agence de la biomédecine do?
Agence de la biomédecine is the French national public health agency that coordinates, regulates, and oversees activities related to organ and tissue donation and transplantation, bone marrow and cord blood registries, medically assisted reproduction, gamete donation, medical genetics, prenatal and preimplantation diagnosis, embryo research oversight, neuroscience policy monitoring, and breast milk donation. It manages national donor registries, allocates organs to patients on transplant waiting lists, authorizes assisted reproduction centers, and publishes annual biovigilance and AMP vigilance reports.
Is Agence de la biomédecine a public or private company?
Agence de la biomédecine is a private company. It is classified as state government owned and is currently operating.
When was Agence de la biomédecine founded?
Agence de la biomédecine was founded in 2004. It employs 251 to 500 people.
Where is Agence de la biomédecine based?
Agence de la biomédecine is headquartered in La Plaine-saint-denis, France, in the Europe region.
Who are Agence de la biomédecine's main competitors?
European Society for Blood and Marrow Transplantation (EBMT) is listed as an others. Direct peers are Deutsche Stiftung Organtransplantation (DSO), Canadian Blood Services, Organización Nacional de Trasplantes (ONT), National Marrow Donor Program / Be The Match, Centro Nazionale Trapianti (CNT) and NHS Blood and Transplant. Australian Organ and Tissue Authority is listed as a regional player.
Does Agence de la biomédecine have an API?
No public API is recorded for Agence de la biomédecine.
What industry is Agence de la biomédecine in?
Agence de la biomédecine's product category is Public Health Biomedicine Services. Its primary akta.pro industry code is BPAGACAJ, Blood, Organ & Tissue Donation Organizations, with a secondary code of HLAJADAB, Biologics & Vaccine Regulators. Its NAICS code is 621991 and its SIC code is 2836.